Royal Biologics Launches MAGNUS DMSO-Free Viable Cellular Bone Allograft

Royal Biologics launched MAGNUS, a viable cellular bone allograft. MAGNUS employs viable spine-derived cells collected from a donor's vertebral body that are preserved with a next-generation DMSO-free cryoprotectant.

Industry standard DMSO penetrates and dehydrates the cell from within to prevent crystal formation. At room temperature,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us